The U.S. Supreme Court Rejects Effort to Ease Cannabis Restrictions

An attempt to remove cannabis from its Schedule I status has been shot down by the U.S. Supreme Court.

Three years ago, a group of cannabis advocates comprised of athletes, veterans, and medical patients, launched a lawsuit against the U.S. Drug Enforcement Administration in attempts to remove cannabis from the Schedule I status under the Controlled Substances Act.

As we’ve discussed previously here at The Green Fund, the Schedule I status of cannabis and marijuana products comes with its own host of issues and contradictions;

Schedule I status was designed to include all of the “hardest” drugs that had no medicinal benefit while having a high potential for abuse. Other drugs alongside cannabis in the Schedule I status are LSD, MDMA, heroin, magic mushrooms, and several others.

The issue, however, with being placed in this “no-go zone” of drugs, is that it makes researching Schedule I drugs much more difficult.

According to a study entitled ‘The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research,’ the federal illegality of cannabis remains a huge barrier to researchers looking to determine the potential…